[FDA] Nabota 100u
[FDA] Nabota 100u
Botulinum toxin type A (Nabota) is indicated for the temporary treatment of glabellar lines associated with cardboard lines and / or decreased abdominal muscle activity in adult patients less than 65 years of age. Botulinum toxin type A (Nabota) is indicated for the treatment of focal armpit hyperhidrosis.
Description
Botulinum toxin type A (Nabota) is indicated for the temporary improvement in the appearance of the upper respiratory tract (forehead lines, crow's feet and forehead lines) in adults. Botulinum toxin type A (Nabota) is indicated for the prevention of headaches in adults with chronic migraine.
Botulinum toxin type A (Nabota) is indicated for the treatment of urinary incontinence due to neurogenic detrusor overactivity, e.g., spinal cord injury (SCI) or multiple sclerosis (MI) in adults.
INDICATION
Composition: volume - 100 units
The package includes a glass ampoule in which the powder is placed under pressure. Sometimes the ampoule may seem empty. For use, dilute the powder in the ampoule with saline. For 100 units, add 2.5 ml of saline, for 200 units - 5 ml of saline.
Disclaimer:
Products on our website are intended for use by qualified healthcare professionals only.
We are not responsible for any adverse effects from self-administration or for compensation of wasted or misused products.
The information on this page is not a substitute for rofessional medical advice, diagnosis or treatment. Always consult a professional healthcare provider for a personalized medical guidance.
We are not responsible for any side effects such as allergic reactions, etc. that may arise after administering the products.